REICH, K.; GOODFIELD, M.; GREEN, L.; NOGRALES, K.; LEVI, E.; LANGLEY, R. G. Safety and Efficacy of Apremilast Through 104 Weeks in Patients swith Moderate-to-Severe Psoriasis Who Continued on Apremilast or Switched from Etanercept Treatment in the LIBERATE Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s32, 2017. DOI: 10.25251/skin.1.supp.31. Disponível em: https://www.jofskin.org/index.php/skin/article/view/117. Acesso em: 16 may. 2022.